NDC 62064-241

EGRIFTA SV

Tesamorelin

EGRIFTA SV is a Subcutaneous Kit in the Human Prescription Drug category. It is labeled and distributed by Theratechnologies Inc.. The primary component is .

• Product ID: 62064-241_2513ba67-f9ff-4320-a5a7-ce2aff1ff2ba
• NDC: 62064-241
• Product Type: Human Prescription Drug
• Proprietary Name: EGRIFTA SV
• Generic Name: Tesamorelin
• Dosage Form: Kit
• Route of Administration: SUBCUTANEOUS
• Marketing Start Date: 2019-11-04
• Marketing Category: NDA / NDA
• Application Number: NDA022505
• Labeler Name: Theratechnologies Inc.
• Active Ingredient Strength: 0
• NDC Exclude Flag: N
• Listing Certified Through: 2020-12-31

Packaging

NDC 62064-241-30

1 KIT in 1 BOX (62064-241-30) * 30 BOTTLE in 1 TRAY > 10 mL in 1 BOTTLE * .5 mL in 1 VIAL

• Marketing Start Date: 2019-11-04
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 62064-241-30 [62064024130]

EGRIFTA SV KIT

• Marketing Category: BLA
• Application Number: BLA022505
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2019-11-04

Drug Details

NDC Crossover Matching brand name "EGRIFTA SV" or generic name "Tesamorelin"

NDC	Brand Name	Generic Name
62064-241	EGRIFTA SV	tesamorelin
62064-011	Egrifta	tesamorelin
62064-041	Egrifta	tesamorelin